Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases

• DOI: 10.1111/iju.15542
• Publication Date: 2024-07-16T05:39:10Z
• Authors: Soichiro Yoshida; Yuya Maezawa; Kensaku Ishihara; Naoki Inoue; Kenji Tanabe; Keita Izumi; Motohiro Fujiwara; Masahiro Toide; Takanobu Yamamoto; Sho Uehara; Saori Araki; Masaharu Inoue; Ryoji Takazawa; Noboru Numao; Yukihiro Ohtsuka; Hajime Tanaka; Yasuhisa Fujii
• Keywords: 03 medical and health sciences; 0302 clinical medicine

To evaluate the clinical characteristics of oligometastatic disease (OMD) in metastatic urothelial carcinoma (mUC) with visceral metastases when classified into synchronous and metachronous metastases.